A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate
Clinical trial NCT00578305 · COMPLETED
Trial details
- NCT number
- NCT00578305
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-11-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.